BDBM518406 2-[4-[2-[(2S)-2-Methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-1-piperazin-1-yl-ethanone::US11124500, Example 1

SMILES C[C@H]1CCN1c1nc(cc(n1)C(F)(F)F)-c1cnn(CC(=O)N2CCNCC2)c1

InChI Key InChIKey=HAUDFIFEGDNKJX-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 518406   

TargetKetohexokinase(Human)
Eli Lilly

US Patent
LigandPNGBDBM518406(US11124500, Example 1 | 2-[4-[2-[(2S)-2-Methylazet...)
Affinity DataIC50: 20.7nMAssay Description:The intrinsic potency for inhibition of KHK C or A activity may be measured using an enzymatic assay which measures the production of FIP. Compounds ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
Go to US Patent

TargetIsoform A of Ketohexokinase (Peripheral)(Human)
Eli Lilly

US Patent
LigandPNGBDBM518406(US11124500, Example 1 | 2-[4-[2-[(2S)-2-Methylazet...)
Affinity DataIC50: 24.2nMAssay Description:The intrinsic potency for inhibition of KHK C or A activity may be measured using an enzymatic assay which measures the production of FIP. Compounds ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
Go to US Patent

TargetKetohexokinase(Human)
Eli Lilly

US Patent
LigandPNGBDBM518406(US11124500, Example 1 | 2-[4-[2-[(2S)-2-Methylazet...)
Affinity DataIC50: 20nMAssay Description:Inhibition of human KHK-C preincubated for 15 mins followed by substrate addition and measured after 20 mins in presence of ATP by Rapidfire MS analy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetKetohexokinase(Human)
Eli Lilly

US Patent
LigandPNGBDBM518406(US11124500, Example 1 | 2-[4-[2-[(2S)-2-Methylazet...)
Affinity DataIC50: 24nMAssay Description:Inhibition of human KHK-A preincubated for 15 mins followed by substrate addition and measured after 20 mins in presence of ATP by Rapidfire MS analy...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetKetohexokinase(Human)
Eli Lilly

US Patent
LigandPNGBDBM518406(US11124500, Example 1 | 2-[4-[2-[(2S)-2-Methylazet...)
Affinity DataIC50: 41nMAssay Description:Inhibition of KHK in human HepG2 cells incubated for 3 hrs by Rapidfire MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed